Prescribing Vibrant Is Fast and Easy

Vibrant is indicated for the treatment of adults with chronic idiopathic constipation who have not experienced relief of their bowel symptoms by using laxative therapies at the recommended dosage for at least 1 month.

How to prescribe

Select Vibrant in your EHR

* For a new patient – select code 60009-0189-82
* For a monthly refill – select code 60009-0189-80

Please make sure you include in the prescription notes the patient’s ICD-10 diagnosis code(s) as well as any previous use of prescribed constipation medications.

How to choose Carepoint in your EHR
* Search by zip code – 60173
* Verify address of pharmacy prior to sending prescription – 9 E. Commerce Drive, Schaumburg, IL
* Add to favorites for convenience

Please note that Vibrant is available only via Carepoint.
You can also fax the prescription directly to (855) 237-9113.

Product NameVibrant Starter Kit
NDC60009-0189-82
IndicationTreatment of chronic idiopathic constipation
Dosage FormCapsule
Dispense Quantity1
Dispense Unit1 ea Box
Number of Supply in One Box1 Pod, 20 Capsules
Days Supply30 days
SIGAs directed by a physician. Orally ingested up to 5 times per week. The Capsules should be taken once daily, on any of the 5 days out of the week, shortly before going to sleep.
Notes to PharmacistRelevant ICD-10 Code for CIC and examples of previous medications tried and failed for treatment may streamline Prior Authorization Process
Specialty PharmacyCarepoint Pharmacy 9 E. Commerce Drive Schaumburg, IL 60173 (855) 237-9112

Example Dosing Screenshot:

Product NameVibrant Capsule (Refill)
NDC60009-0189-80
IndicationTreatment of chronic idiopathic constipation
Dosage FormCapsule
Dispense Quantity20
Dispense UnitCapsule
Number of Supply in One Box20 Capsules
Days Supply30 days
SIGAs directed by a physician. Orally ingested up to 5 times per week. The Capsules should be taken once daily, on any of the 5 days out of the week, shortly before going to sleep.
Notes to PharmacistRelevant ICD-10 Code for CIC and examples of previous medications tried and failed for treatment may streamline Prior Authorization Process
Specialty PharmacyCarepoint Pharmacy 9 E. Commerce Drive Schaumburg, IL 60173 (855) 237-9112

Example Dosing Screenshot:

Contact us about patient options for participating in our post-market clinical trial, enabling additional clinical data collection.

If you can’t find Vibrant in your EHR or have questions, email us at [email protected]

Vibrant should not be used if your patient

  • has a history of complicated/obstructive diverticular disease.
  • has a history of intestinal or colonic obstruction, or suspected intestinal obstruction.
  • currently has clinical evidence of significant gastroparesis.
  • has a history of significant gastrointestinal disorder, including any form of inflammatory bowel disease or gastrointestinal malignancy (celiac disease is excepted if the subject has been treated and is in remission), and/or anal fissures and fistulas.
  • has a history of Zenker’s diverticulum, dysphagia, esophageal stricture, eosinophilic esophagitis, or achalasia.
  • is pregnant or lactating.

Adverse events/side effects:

Potential adverse events associated with the use of this device may include abdominal pain, abdominal distension, abdominal discomfort, vomiting, nausea, blood in stool, diarrhea, flatulence, and proctalgia. In rare cases, obstruction may occur.

Note that the safety and effectiveness of the Vibrant System for long-term use in the indicated population, i.e., for more than 8 weeks, has not been evaluated.

Warnings:

  • The Vibrant Capsule is MR unsafe. The device has not been evaluated for safety and compatibility in the MR (magnetic resonance) environment. It has not been tested for heating, migration, or image artifact in the MR (magnetic resonance) environment. If patient requires an MRI, verify Capsule expulsion via abdominal X-ray before undergoing an MRI examination.
  • The Capsule should be kept away from implants such as pacemakers, defibrillators, nerve stimulators, and other devices that could be affected by proximity to a DC (direct current) magnetic field.
  • Vibrant Capsules must be stored in a safe place, out of the reach of children and/or infants.
  • If a child has accidentally swallowed an unused Vibrant Capsule, he/she should be brought immediately to a hospital.

What do your colleagues think about the phase 3 clinical results?

Receive a quick online training video on Vibrant.

The training is only 7 minutes long, covering information about Vibrant, phase 3 data, and how to prescribe to suitable patients.